AVCURI Trademark

Trademark Overview


On Thursday, December 30, 2021, a trademark application was filed for AVCURI with the United States Patent and Trademark Office. The USPTO has given the AVCURI trademark a serial number of 97196466. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Thursday, December 19, 2024. This trademark is owned by Actinium Pharmaceuticals, Inc.. The AVCURI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in a preparatory regime for bone marrow transplantation; pharmaceutical preparations for depleting cells expressing CD45 antigen; radiopharmaceutical antibody preparations
avcuri

General Information


Serial Number97196466
Word MarkAVCURI
Filing DateThursday, December 30, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateThursday, December 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations for use in oncology; pharmaceutical preparations for use in a preparatory regime for bone marrow transplantation; pharmaceutical preparations for depleting cells expressing CD45 antigen; radiopharmaceutical antibody preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 5, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameActinium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NameActinium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10016

Trademark Events


Event DateEvent Description
Wednesday, October 5, 2022ASSIGNED TO EXAMINER
Monday, January 3, 2022NEW APPLICATION ENTERED
Wednesday, January 5, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 2, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 22, 2022PUBLISHED FOR OPPOSITION
Tuesday, November 22, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 23, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 23, 2023SOU EXTENSION 1 FILED
Friday, June 23, 2023SOU EXTENSION 1 GRANTED
Tuesday, June 27, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 9, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, January 9, 2024SOU EXTENSION 2 FILED
Tuesday, January 9, 2024SOU EXTENSION 2 GRANTED
Thursday, January 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 3 FILED
Thursday, December 19, 2024SOU EXTENSION 4 FILED
Thursday, December 19, 2024SOU EXTENSION 4 GRANTED
Monday, April 29, 2024SOU EXTENSION 3 GRANTED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 19, 2024SOU TEAS EXTENSION RECEIVED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED